http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP19020228-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2019-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f80f6f8dda63d7014f1a6837471129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294fb52ddd898fe568b4150cf93b9501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077830f1ba82f044d887aeeb3c726261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d40b089bb693fa18a95c378e1ddb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b45286a84b69ecab6b1e9821163d3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abee21527735efffdd9f4dc2079db060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c14b89436454d3e04296263c906a6013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_041c7dd6c869b06cc143a20596668a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f3b2711c66c2496987af44f1078e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb89d87d63348a78bf26ee7ab729d03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b7fa6d40d4bbb139d3e6e86d85a323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c48d2913de9844046aee33159d61b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d4398ae76681ec115e97a60e4aeb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dafb8887a690b8e61c6fa549533f3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21921663cfbd1e757101b6370030b78e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a541e11af0fd975d870d5e7cc8ed2bba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dcfaf8098edd3487186355d9f0a239e
publicationDate 2019-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP19020228-A
titleOfInvention PYRAZOLOPYRIDINE DERIVATIVE HAVING THE AGONIST EFFECT OF THE GLP-1 RECEPTOR
abstract The present invention provides a compound represented by Formula (I) wherein an indole ring or a pyrrolo [2,3-b] pyridine ring and a pyrazolopyridine backbone are attached by a substituent, or a salt of the compound; solvates of this; and preventive or therapeutic agents against non-insulin-dependent diabetes mellitus (type 2 diabetes), obesity, and the like wherein said compound, salt or solvate is used as an active ingredient. (In the formula X, Y, Q1, Q2, R1, R2, R3, R4, R5, R6, R7, R8, R9, n1, n2, Z1, and Z2 represent the substances indicated in the specification).
priorityDate 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426246568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411491944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21643653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9222

Total number of triples: 64.